2013
DOI: 10.1038/labinvest.2013.5
|View full text |Cite
|
Sign up to set email alerts
|

CXCL5 stimulation of RANK ligand expression in Paget's disease of bone

Abstract: Paget's disease of bone (PDB) is a chronic focal skeletal disorder that affects 2-3% of the population over 55 years of age. PDB is marked by highly localized areas of bone turnover with increased osteoclast activity. Evidence suggests a functional role for measles virus nucleocapsid protein (MVNP) in the pathogenesis of PDB. In the present study, we identified elevated levels (B180-fold) of CXCL5 mRNA expression in bone marrow cells from patients with PDB compared with that in normal subjects. In addition, CX… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
13
0
2

Year Published

2015
2015
2022
2022

Publication Types

Select...
8
1

Relationship

3
6

Authors

Journals

citations
Cited by 19 publications
(15 citation statements)
references
References 45 publications
0
13
0
2
Order By: Relevance
“…It is possible that other CXCR2 ligands, specifically CXCL8 (IL-8) and CXCL5, could contribute to the adipocyte-induced effects on osteoclasts. Both chemokines have been shown to stimulate osteoclast differentiation and activity [27, 67, 68] and both are reported to be present in the adipose tissue; however their expression is associated primarily with non-adipose (stromal) component of fat tissue [69-71]. This suggests that marrow adipocyte-induced CXCR2 signaling in osteoclasts is likely driven by CXCL1 and CXCL2 chemokines.…”
Section: Discussionmentioning
confidence: 99%
“…It is possible that other CXCR2 ligands, specifically CXCL8 (IL-8) and CXCL5, could contribute to the adipocyte-induced effects on osteoclasts. Both chemokines have been shown to stimulate osteoclast differentiation and activity [27, 67, 68] and both are reported to be present in the adipose tissue; however their expression is associated primarily with non-adipose (stromal) component of fat tissue [69-71]. This suggests that marrow adipocyte-induced CXCR2 signaling in osteoclasts is likely driven by CXCL1 and CXCL2 chemokines.…”
Section: Discussionmentioning
confidence: 99%
“…More recently, it has been demonstrated that MVNP induction of IL-6 in OCL cells results in elevated levels of IGF-1 which in turn increases the expression of coupling factors, ephrinB2 on OCLs and EphB4 on osteoblasts, thereby enhancing the OCL driven osteoblast activity in PDB ( Teramachi et al, 2016 ). Earlier, we showed that patients with PDB contain elevated levels of FGF-2 and chemokine CXCL5 which modulates osteoclastogenesis through induction of RANKL expression in osteoblast cells ( Sundaram et al, 2009 , Sundaram et al, 2013 ). Therefore, MVNP regulation of SIRPβ1 signaling in OCL cells could modulate secretory factors which influence OCL/osteoblast activity.…”
Section: Discussionmentioning
confidence: 98%
“…Earlier, we showed that patients with PDB contain elevated levels of FGF-2 and chemokine CXCL5, which modulate osteoclastogenesis through induction of RANKL expression in osteoblast cells [19,29]. Since the pagetic OCL contain MVNP and shown directly induces osteoclastogenesis, it is important to unravel the underlying molecular mechanisms to determine the pathogenesis of PDB.…”
Section: Discussionmentioning
confidence: 99%